These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity. Adamson RH Cancer Chemother Rep; 1974; 58(3):293-4. PubMed ID: 4841712 [No Abstract] [Full Text] [Related]
5. Recent developments in the field of antitumour anthracyclines. Monneret C Eur J Med Chem; 2001 Jun; 36(6):483-93. PubMed ID: 11525839 [No Abstract] [Full Text] [Related]
6. Editorial: Adriamycin and the heart. Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302 [No Abstract] [Full Text] [Related]
7. Daunorubicin and adriamycin in the treatment of leukemia. Klener P; Donner L; Kozená J Neoplasma; 1973; 20(1):87-96. PubMed ID: 4573873 [No Abstract] [Full Text] [Related]
8. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127). Wheeler DM Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002 [No Abstract] [Full Text] [Related]
9. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review. Trouet A; Sokal G Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556 [TBL] [Abstract][Full Text] [Related]
10. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy. Benjamin RS; Mason JW; Billingham ME Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871 [No Abstract] [Full Text] [Related]
11. [Serial determination of anthracycline poisoning in children]. Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725 [TBL] [Abstract][Full Text] [Related]
12. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948 [No Abstract] [Full Text] [Related]
13. The role of calcium in the toxicity of the myocardium. Borgers M Histochem J; 1981 Sep; 13(5):839-48. PubMed ID: 7298378 [No Abstract] [Full Text] [Related]
14. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy]. Svojgrová M; Slechtová J; Hůla J Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075 [TBL] [Abstract][Full Text] [Related]
15. Anthracycline cardiotoxicity and acute myelogenous leukaemia. Al-Ismail SA; Parry DH; Whittaker JA Br Med J; 1977 Mar; 1(6064):815. PubMed ID: 265741 [No Abstract] [Full Text] [Related]
16. Relationship between chromosomal aberrations and nuclear alterations induced in cultured rat heart cells by adriamycin. Lee YS; Lieu TL Taiwan Yi Xue Hui Za Zhi; 1988 Sep; 87(9):857-65. PubMed ID: 3221185 [No Abstract] [Full Text] [Related]
18. Anthracyclines selectively decrease alpha cardiac actin mRNA abundance in the rat heart. Papoian T; Lewis W Am J Pathol; 1992 Nov; 141(5):1187-95. PubMed ID: 1443052 [TBL] [Abstract][Full Text] [Related]
19. Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin. Hurteloup P; Ganzina F Drugs Exp Clin Res; 1986; 12(1-3):233-46. PubMed ID: 3525075 [TBL] [Abstract][Full Text] [Related]
20. On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors. Lenaz L; Di Marco A Cancer Chemother Rep; 1972 Aug; 56(4):431-2. PubMed ID: 5081585 [No Abstract] [Full Text] [Related] [Next] [New Search]